A systematic review of the epidemiology and histopathological findings of pulmonary thrombi at covid-19

Detalhes bibliográficos
Autor(a) principal: Persiano, Camille Bastos
Data de Publicação: 2021
Outros Autores: Lima, Isabela Lopes, Meirelles, Gabriel Alves, Carvalho, Arthur Alves Borges de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/16983
Resumo: Some of the pacients affected by COVID-19 present thrombi. The objective of this study was to assess the association between comorbidities of COVID-19 and thrombi in the lungs. Articles with the descriptors “Pathology”, “Autopsy”, “COVID-19”, “SARS-CoV-2” were extracted from the databases: Medical Literature Analysis and Retrieval System Online (MEDLINE/PUBMED), Cochrane Library, Virtual Health Library (VHL), Web of Science and Scopus. Eligibility criteria were: articles in English, published between January 1 and May 28, 2020, with confirmed cases of COVID-19, with description of necropsy and analysis pulmonary histopathological. The data were tabulated: age, sex, comorbidities, time of disease evolution and macro and microscopic findings of the lungs. Twenty articles were included, totaling 119 necropsies, most of them original articles or case reports Regarding gender, 86 were male, 23 female and 10 were undetermined. Seventy-five of the individuals included had thrombi in the lungs, among these, 98.7% had diffuse alveolar damage (DAD). male or that patients with hypertension, diabetes or deep vein thrombosis (DVT) were more likely to have thrombi in their lungs. Approximately 70% of the analyzed patients were between 60 and 89 years old. The average length of hospital stay was 6.4 days. In 90.7% of the pulmonary histological samples, aspects of DAD were identified. Of the macroscopic findings of the lungs, the most prevalent was “heavy lungs”, of which 92.1% had thrombi. Hospitalized patients have a greater chance of dying within the 9th day of hospitalization. The work identified cases of thrombi in the lungs more frequently in individuals with DVT, diabetes and hypertension.
id UNIFEI_0a0212346b8de0dbb13e3d27dcaef02a
oai_identifier_str oai:ojs.pkp.sfu.ca:article/16983
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling A systematic review of the epidemiology and histopathological findings of pulmonary thrombi at covid-19Una revisión sistemática de los resultados epidemiológicos e histopatológicos de las trombas pulmonares en covid-19Uma revisão sistemática da epidemiologia e achados histopatológicos de trombos pulmonares na covid-19 PathologyAutopsyHistopathologyCoronavirus infections.PatologíaAutopsiaHistopatológicoInfecciones por coronavirus.PatologiaAutopsiaHistopatológicoInfecções por coronavírus.Some of the pacients affected by COVID-19 present thrombi. The objective of this study was to assess the association between comorbidities of COVID-19 and thrombi in the lungs. Articles with the descriptors “Pathology”, “Autopsy”, “COVID-19”, “SARS-CoV-2” were extracted from the databases: Medical Literature Analysis and Retrieval System Online (MEDLINE/PUBMED), Cochrane Library, Virtual Health Library (VHL), Web of Science and Scopus. Eligibility criteria were: articles in English, published between January 1 and May 28, 2020, with confirmed cases of COVID-19, with description of necropsy and analysis pulmonary histopathological. The data were tabulated: age, sex, comorbidities, time of disease evolution and macro and microscopic findings of the lungs. Twenty articles were included, totaling 119 necropsies, most of them original articles or case reports Regarding gender, 86 were male, 23 female and 10 were undetermined. Seventy-five of the individuals included had thrombi in the lungs, among these, 98.7% had diffuse alveolar damage (DAD). male or that patients with hypertension, diabetes or deep vein thrombosis (DVT) were more likely to have thrombi in their lungs. Approximately 70% of the analyzed patients were between 60 and 89 years old. The average length of hospital stay was 6.4 days. In 90.7% of the pulmonary histological samples, aspects of DAD were identified. Of the macroscopic findings of the lungs, the most prevalent was “heavy lungs”, of which 92.1% had thrombi. Hospitalized patients have a greater chance of dying within the 9th day of hospitalization. The work identified cases of thrombi in the lungs more frequently in individuals with DVT, diabetes and hypertension.Algunos de los pacientes afectados por COVID-19 tienen trombos. Este estudio tuvo como objetivo evaluar la asociación entre comorbilidades de COVID-19 y trombos en los pulmones. Los artículos con los descriptores “Patología”, “Autopsia”, “COVID-19”, “SARS-CoV-2” fueron extraídos de las bases de datos: Medical Literature Analysis and Retrieval System Online (MEDLINE / PUBMED), Cochrane Library, Library Virtual Health (VHL), Web of Science y Scopus Los criterios de elegibilidad fueron: artículos en inglés, publicados entre el 1 de enero y el 28 de mayo de 2020, con casos confirmados de COVID-19, con descripción de necropsia y análisis histopatológico Se tabularon los siguientes datos: edad, sexo, comorbilidades, tiempo de evolución de la enfermedad y hallazgos macroscópicos y microscópicos pulmonares.Se incluyeron 20 artículos, totalizando 119 necropsias, la mayoría originales o reportes de casos, 86 eran masculinos, 23 femeninos y 10 indeterminados. cinco de los individuos incluidos tenían trombos en los pulmones, entre estos, el 98,7% presentaba daño alveolar difuso (DAD). hipertensión, la diabetes o la trombosis venosa profunda (TVP) tenían más probabilidades de tener trombos en los pulmones. Aproximadamente el 70% de los pacientes analizados tenían entre 60 y 89 años. La duración media de la estancia hospitalaria fue de 6,4 días. En el 90,7% de las muestras histológicas pulmonares se identificaron aspectos de DAD. De los hallazgos macroscópicos de los pulmones, el más prevalente fue el de “pulmones pesados”, de los cuales el 92,1% presentaba trombos. Los pacientes hospitalizados tenían una mayor probabilidad de morir al noveno día de hospitalización. El trabajo identificó casos de trombos en los pulmones con mayor frecuencia en personas con TVP, diabetes e hipertensión.Alguns dos pacientes afetados pela COVID-19 apresentam trombos. Este estudo teve como objetivo avaliar a associação entre comorbidades da COVID-19 e trombos nos pulmões. Extraíram-se artigos com os descritores “Pathology”, “Autopsy”, “COVID-19”, "SARS-CoV-2” nos bancos de dados: Medical Literature Analysis and Retrieval System Online (MEDLINE/PUBMED), Biblioteca Cochrane, Biblioteca Virtual em Saúde (BVS), Web of Science e Scopus.  Os critérios de elegibilidade foram: artigos em inglês, publicados entre 1 de janeiro a 28 de maio de 2020, com casos confirmados de COVID-19, com descrição de necrópsia e análise histopatológica pulmonar. Tabulou-se os dados: idade, sexo, comorbidades, tempo de evolução da doença e achados macro e microscópicos dos pulmões. Vinte artigos foram incluídos, totalizando 119 necrópsias, a maioria deles eram artigos originais ou relatos de caso. Acerca do sexo, 86 eram do masculino, 23 do feminino e 10 eram indeterminados.  Setenta e cinco dos indivíduos incluídos apresentaram trombos nos pulmões, dentre esses, 98,7% apresentaram dano alveolar difuso (DAD). Pacientes que eram ou do sexo masculino ou que apresentavam hipertensão, diabetes ou trombose venosa profunda (TVP) tiveram mais chances de ter trombos nos pulmões. Aproximadamente 70% dos pacientes analisados tinham entre 60 e 89 anos. A média do tempo de hospitalização foi de 6,4 dias. Em 90,7% das amostras histológicas pulmonares foram identificados aspectos da DAD. Dos achados macroscópicos dos pulmões, o mais prevalente foi “pulmões pesados”, desses, 92,1% apresentaram trombos. Pacientes internados tiveram uma chance maior de vir a óbito até o 9º dia de internação. O trabalho identificou casos de trombos em pulmões com maior frequência em indivíduos com TVP, diabetes e hipertensão.Research, Society and Development2021-07-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1698310.33448/rsd-v10i8.16983Research, Society and Development; Vol. 10 No. 8; e0410816983Research, Society and Development; Vol. 10 Núm. 8; e0410816983Research, Society and Development; v. 10 n. 8; e04108169832525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/16983/15151Copyright (c) 2021 Camille Bastos Persiano; Isabela Lopes Lima; Gabriel Alves Meirelles; Arthur Alves Borges de Carvalhohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessPersiano, Camille BastosLima, Isabela LopesMeirelles, Gabriel AlvesCarvalho, Arthur Alves Borges de2021-08-21T18:46:59Zoai:ojs.pkp.sfu.ca:article/16983Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:37:23.724492Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv A systematic review of the epidemiology and histopathological findings of pulmonary thrombi at covid-19
Una revisión sistemática de los resultados epidemiológicos e histopatológicos de las trombas pulmonares en covid-19
Uma revisão sistemática da epidemiologia e achados histopatológicos de trombos pulmonares na covid-19
title A systematic review of the epidemiology and histopathological findings of pulmonary thrombi at covid-19
spellingShingle A systematic review of the epidemiology and histopathological findings of pulmonary thrombi at covid-19
Persiano, Camille Bastos
Pathology
Autopsy
Histopathology
Coronavirus infections.
Patología
Autopsia
Histopatológico
Infecciones por coronavirus.
Patologia
Autopsia
Histopatológico
Infecções por coronavírus.
title_short A systematic review of the epidemiology and histopathological findings of pulmonary thrombi at covid-19
title_full A systematic review of the epidemiology and histopathological findings of pulmonary thrombi at covid-19
title_fullStr A systematic review of the epidemiology and histopathological findings of pulmonary thrombi at covid-19
title_full_unstemmed A systematic review of the epidemiology and histopathological findings of pulmonary thrombi at covid-19
title_sort A systematic review of the epidemiology and histopathological findings of pulmonary thrombi at covid-19
author Persiano, Camille Bastos
author_facet Persiano, Camille Bastos
Lima, Isabela Lopes
Meirelles, Gabriel Alves
Carvalho, Arthur Alves Borges de
author_role author
author2 Lima, Isabela Lopes
Meirelles, Gabriel Alves
Carvalho, Arthur Alves Borges de
author2_role author
author
author
dc.contributor.author.fl_str_mv Persiano, Camille Bastos
Lima, Isabela Lopes
Meirelles, Gabriel Alves
Carvalho, Arthur Alves Borges de
dc.subject.por.fl_str_mv Pathology
Autopsy
Histopathology
Coronavirus infections.
Patología
Autopsia
Histopatológico
Infecciones por coronavirus.
Patologia
Autopsia
Histopatológico
Infecções por coronavírus.
topic Pathology
Autopsy
Histopathology
Coronavirus infections.
Patología
Autopsia
Histopatológico
Infecciones por coronavirus.
Patologia
Autopsia
Histopatológico
Infecções por coronavírus.
description Some of the pacients affected by COVID-19 present thrombi. The objective of this study was to assess the association between comorbidities of COVID-19 and thrombi in the lungs. Articles with the descriptors “Pathology”, “Autopsy”, “COVID-19”, “SARS-CoV-2” were extracted from the databases: Medical Literature Analysis and Retrieval System Online (MEDLINE/PUBMED), Cochrane Library, Virtual Health Library (VHL), Web of Science and Scopus. Eligibility criteria were: articles in English, published between January 1 and May 28, 2020, with confirmed cases of COVID-19, with description of necropsy and analysis pulmonary histopathological. The data were tabulated: age, sex, comorbidities, time of disease evolution and macro and microscopic findings of the lungs. Twenty articles were included, totaling 119 necropsies, most of them original articles or case reports Regarding gender, 86 were male, 23 female and 10 were undetermined. Seventy-five of the individuals included had thrombi in the lungs, among these, 98.7% had diffuse alveolar damage (DAD). male or that patients with hypertension, diabetes or deep vein thrombosis (DVT) were more likely to have thrombi in their lungs. Approximately 70% of the analyzed patients were between 60 and 89 years old. The average length of hospital stay was 6.4 days. In 90.7% of the pulmonary histological samples, aspects of DAD were identified. Of the macroscopic findings of the lungs, the most prevalent was “heavy lungs”, of which 92.1% had thrombi. Hospitalized patients have a greater chance of dying within the 9th day of hospitalization. The work identified cases of thrombi in the lungs more frequently in individuals with DVT, diabetes and hypertension.
publishDate 2021
dc.date.none.fl_str_mv 2021-07-03
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/16983
10.33448/rsd-v10i8.16983
url https://rsdjournal.org/index.php/rsd/article/view/16983
identifier_str_mv 10.33448/rsd-v10i8.16983
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/16983/15151
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 10 No. 8; e0410816983
Research, Society and Development; Vol. 10 Núm. 8; e0410816983
Research, Society and Development; v. 10 n. 8; e0410816983
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052751370256384